TCBPW
Price:
$0.021
Market Cap:
$323.96K
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.[Read more]
Industry
Biotechnology
IPO Date
Stock Exchange
NASDAQ
Ticker
TCBPW
According to TC Biopharm (Holdings) Plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -109.92% compared to the average of 0.30 of the last 4 quarters.
The mean historical PE Ratio of TC Biopharm (Holdings) Plc over the last ten years is -2.88. The current -0.03 PE Ratio has changed 4.06% with respect to the historical average. Over the past ten years (40 quarters), TCBPW's PE Ratio was at its highest in in the June 2023 quarter at 1.68. The PE Ratio was at its lowest in in the September 2020 quarter at -6.47.
Average
-2.88
Median
-2.25
Minimum
-5.38
Maximum
-0.13
Discovering the peaks and valleys of TC Biopharm (Holdings) Plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.91%
Maximum Annual PE Ratio = -0.13
Minimum Annual Increase = -92.17%
Minimum Annual PE Ratio = -5.38
Year | PE Ratio | Change |
---|---|---|
2023 | -0.13 | -92.17% |
2022 | -1.67 | -26.10% |
2021 | -2.25 | -58.12% |
2020 | -5.38 | 7.91% |
The current PE Ratio of TC Biopharm (Holdings) Plc (TCBPW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.35
5-year avg
-2.88
10-year avg
-2.88
TC Biopharm (Holdings) Plc’s PE Ratio is greater than Protagenic Therapeutics, Inc. (-0.42), greater than bioAffinity Technologies, Inc. (-1.79), greater than American Rebel Holdings, Inc. (-0.79), greater than Alvotech (-5.88), greater than Inspira Technologies Oxy B.H.N. Ltd. (-2.46),
Company | PE Ratio | Market cap |
---|---|---|
-0.42 | $2.85M | |
-1.79 | $13.49M | |
-0.79 | $2.29M | |
-5.88 | $4.12B | |
-2.46 | $24.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TC Biopharm (Holdings) Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TC Biopharm (Holdings) Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is TC Biopharm (Holdings) Plc's PE Ratio?
How is the PE Ratio calculated for TC Biopharm (Holdings) Plc (TCBPW)?
What is the highest PE Ratio for TC Biopharm (Holdings) Plc (TCBPW)?
What is the 3-year average PE Ratio for TC Biopharm (Holdings) Plc (TCBPW)?
What is the 5-year average PE Ratio for TC Biopharm (Holdings) Plc (TCBPW)?
How does the current PE Ratio for TC Biopharm (Holdings) Plc (TCBPW) compare to its historical average?